Former AusCann CEO joins MGC Pharma as non-executive director by Steve Jones June 5, 2023June 5, 2023 Former AusCann chief executive Layton Mills has joined the board of MGC Pharma as a non-executive […]
AusCann remains in holding pattern as proposed acquisition is delayed by Steve Jones May 1, 2023May 1, 2023
Company news: Cann Global; Elixinol; Bod Science; AusCann; IvyMed Clinic; Botanix by Steve Jones and Martin Lane April 5, 2023December 12, 2023
AusCann offloads 52% of CannPal to founder Layton Mills in move to ‘unlock potential’ of animal business by Steve Jones March 13, 2023March 13, 2023
Financial results: Elixinol; Emyria; Epsilon; Avecho; Creso Pharma; AusCann; MGC Pharma; Botanix; Zelira by Martin Lane and Steve Jones March 1, 2023March 1, 2023
AusCann boss Layton Mills looks for love in season 10 of Married At First Sight by Martin Lane February 13, 2023August 11, 2023
Eurocann expecting big things from North Macedonian facility by Steve Jones December 1, 2022December 1, 2022
The curious tale of Eurocann’s journey to ASX listing by Steve Jones November 10, 2022November 10, 2022
Company news: Emyria; Ecofibre; Avecho; Medlab; MGC Pharma; AusCann; Botanix; Incannex; GFI by Martin Lane and Steve Jones November 1, 2022November 2, 2022
AusCann invests a further A$3.5m in European venture, sells R&D facility by Steve Jones September 12, 2022September 12, 2022